Chp. 5 Blood and Blood Products Flashcards
What is blood component therapy?
-Involves administration of specific blood product according to need of the clinical condition of the patient
What are available blood products that can be used in SA before, during, and after GA?
- pRBCs
- Fresh frozen plasma
- Cryoprecipitate
- Cryoprecipitate-poor plasma
- PRP
How can practitioners acquire these products if they do not have the capability to process whole blood?
-blood banks
What are common indications for blood component therapy during perioperative period?
-Severe hemorrhage during surgery
-Acute/chronic anemia DT variety of causes -> trauma, neoplasia, chronic inflammation
-Hypoproteineima
-von Willebrand’s Disease
-Coagulopathies (DIC, liver dz)
-Thrombocytopenia
Components of: whole blood
RBCs
Clotting factors
Proteins
vWF
Platelets
Components of: pRBCs
red blood cells only
Components of: fresh frozen plasma
all clotting factors including albumin, vitamin-K dependent proteins
Components of: stored frozen plasma
similar to FFP with reduced concentration of cofactors V and VIII (check this*)
Components of: cryoprecipitate
high concentration of factor VIII, fibrinogen, vWF, fibronectin
Components of: cryoprecipitate-poor plasma
Similar to FFP or SFP with decreased VIII, fibrinogen, vWF, and fibronectin (check this*)
Indications for whole blood
-Massive blood loss (>20% blood volume) before/during GA
-Coagulopathy resulting in massive blood loss
-Some patients with DIC
Indications for pRBCs
-Less severe blood loss during surgery, normovolemic anemia
Indications for FFP
-von Willebrand’s disease
-Hemophila A, B
-Liver disease
-Coagulopathy
-DIC
-Rodenticide intoxication
-Hypoproteinemia
Indications for SFP
-Similar indications as for FFP except in patients with hemophilia A or wVF deficiency
Indications for cryoprecipitate
-DIC
-vWF deficiency
-Hemophilia A
-Generalized sepsis - fibronectin enhances mononuclear
Indications for cryoprecipitate
-DIC
-vWF deficiency
-Hemophilia A
-Generalized sepsis - fibronectin enhances mononuclear phagocytic activity
Indications for cryoprecipitate-free plasma
Similar to FFP or SFP except in conditions that require factor VIII, vWF, and fibronectin
What is the best approach to correcting hypoalbuminemia if you don’t have canine albumin?
-FFP ideally not used as only source of album
-To increase [alb] by 1g/dL, plasma should be given at 45mL/kg -> expensive
-Without concurrent administration of other colloids, albumin from transfused plasma equilibrates rapidly with extravascular space -> consider adding synthetic colloids
Do blood and blood products require special administration sets?
Should be administered through 170um filter bc have micro agglutinates
What are the advantages of blood component therapy in the field of anesthesia?
- Main advantage = minimal volume needed for administration, preventing circulatory overload
In anemic patients with normal blood volume…
- Administration of pRBCs preferable to whole blood
- Colloid component of whole blood can result in vol overload when attempting to increase oxygen-carrying capacity of the patient
What are other advantages to using specific blood components?
- Fewer complications assoc with transfusion bc unnecessary components not administered
- Longer storage time for some components includ. plasma, plasma derivatives
- Better use of blood resources
- Better therapeutic approach to patient’s problem
Which crystalloid solution can be mixed with blood during administration?
- Normal saline (0.9%) can be mixed with blood
- Crystalloid solution that contain calcium will active coagulation system
- Some preparations either hypotonic or hypertonic –> hemolysis
Is there any specific temperature requirement for blood products before administration to patient?
- Blood and blood products, except PRP, should be warmed before transfusion
- Temp should not be warmed to more than 37*C
What is the problem with blood products heated and administered at temps higher than 37*C?
- Higher temperatures will result in hemolysis and precipitation of numerous proteins
At what temperature can PRP be administered?
22*C
Equation for calculating dose of blood and blood products
mL of blood required = Blood volume x (desired PCV - recipient PCV)/Donor PCV
How should blood products be administered?
- Volume administered slowly for first 5-15’ at rate of 5.0mL/kg/hr
- Animal closely observed for adverse reactions
- Rate increased to 10mL/kg/hr if no complications observed
- If patient hypovolemic, rate of infusion increased to 66mL/kg/hr